Nowadays, the country has opened up to accommodate a large number of foreign tourists. Many people may be concerned that COVID-19 Will come back to spread widely again especially among immunocompromised patients from various diseases and patients who need to take immunosuppressant drugs because these patients have a weaker response to the vaccine than the general population. or not responding to the vaccine It is therefore the cause of the development of innovative medicines that give patients the opportunity to return to normal life again with “LAAB” ready-made immunity for at-risk populations.
Many people may be wondering what is the function of the finished immune system that we are talking about. Now let’s answer the doubt that “LAAB” (Long-acting Antibody: Long-acting antibody drug) is a ready-made immunotherapy that has been conditionally registered in Thailand. by the Food and Drug Administration (FDA) approved for use as a preventive injection before exposure to pathogens causing COVID-19 in high-risk patients and immunocompromised patients and injection for the treatment of COVID-19 in patients with mild to moderate symptoms In people aged 12 years and over and weighing at least 40 kg.
To explain simply how LAAB is different from a vaccine…
A vaccine is a substance that is introduced into the body by various means. for the COVID-19 vaccine is an injection into the muscle of the arm To stimulate the body to create immunity or antibodies. The body takes about 2 weeks, while LAAB or ready-made COVID immunity. It is a combination long-acting antibody drug that, once injected into the body, produces immediate immunity. It works in 6 hours, thus helping to boost immunity for vulnerable populations who are less responsive to the vaccine than the general population. or not responding to the vaccine
LAAB is currently used in many areas among immunocompromised patients. both caused by the disease use of immunosuppressants and other causes Related Including expanding its use to the elderly group, including
- People aged 60 and over who have not been vaccinated against COVID-19 or get vaccinated against COVID-19 last dose more than 3 months
- People with chronic diseases, 7 groups of diseases that have not been vaccinated against COVID-19 or get vaccinated against COVID-19 last dose more than 3 months
- end-stage kidney disease patients undergoing renal replacement therapy, both hemodialysis and peritoneal dialysis
- Organ transplant patients
- blood cancer patients or cancer in other organs
- Patients receiving immunosuppressants
- HIV-infected people with a CD4 count of less than 200 cells/mm3.
- other groups of patients that the physician considers should be given medication
Assess immune readiness and look up preliminary information. Assessments can be made at https://www.poomkumjai.com/quiz and learn more at https://www.poomkumjai.com/form However, it is advisable to consult a personal physician as well.